Skip to content
PB
Company

Updated:

PROLOR Biotech, Inc.

PROLOR Biotech, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001268659, and its reported industry is...

Overview

PROLOR Biotech, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001268659, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2013-03-15, it reported annual revenue of USD 0; net income of USD -18,271,434; total assets of USD 35,916,698 for the fiscal period ended 2012-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
PROLOR Biotech, Inc.
Former names in filing history
Modigene Inc. (2007-02-27 to 2009-05-28); LDG INC (2003-11-04 to 2006-12-22)
Classification
Company
Industry (SIC)
2834 — Pharmaceutical Preparations
Headquarters
Nes-Ziona, Israel
Incorporated in
NV
Fiscal year end
December 31
SEC CIK
0001268659

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endRevenueNet incomeTotal assetsCash and equivalentsOperating cash flow
FY2012USD$0-$18.3M$35.9M$23.8M-$16.4M
FY2011USD—-$15.1M$15.0M$13.3M-$12.0M

Recent SEC filings

FormFiledPeriodFiling
8-K8-K
10-Q10-Q
8-KFORM 8-K
8-K8-K
8-K8-K
8-KFORM 8-K
10-Q10-Q
8-KFORM 8-K
DEF 14ADEF 14A
8-KFORM 8-K
10-K10-K
8-KFORM 8-K

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research PROLOR Biotech, Inc. in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles